Nicol P, Perceau G, Barbe C, Bernard P
Dermatology Department, hôpital Robert-Debré, CHU de Reims, avenue du Général-Koenig, 51092 Reims cedex, France.
Dermatology Department, hôpital Robert-Debré, CHU de Reims, avenue du Général-Koenig, 51092 Reims cedex, France.
Ann Dermatol Venereol. 2017 Oct;144(10):582-588. doi: 10.1016/j.annder.2017.02.007. Epub 2017 May 19.
Erosive pustular dermatosis of the leg (EPDL) is a poorly understood entity first described by Lanigan and Cotteril in 1987. Its clinical diagnosis is based on exclusion since the physiopathology is unknown. The primary objective of this investigation was to specify the clinical aspects and outcomes in a prospective study. The secondary objectives were to describe associated diseases, the circumstances of occurrence, and the laboratory tests used.
This was a prospective study that included 45 patients selected by members of the Angiology-Dermatology Group of the SFD (French Dermatology Society) at 13 centres between 01/09/2013 and 31/10/2014. There was a 180-day monitoring period. The records of 36 patients were analysed. Clinical and laboratory data were collected.
Mean patient age was 79.6±9.9 years with a M/F sex ratio of 0.2. Among the patients, 16.7% had skin cancer and 91.7% had venous insufficiency. The proportion of patients wearing venous compression hose was constant between inclusion and D180. Lesions were bilateral (53%), affected the middle third of the leg, and were on the anterior aspect. Complete healing was achieved in 77.8% of cases with time to healing of 2.4±1.2 months, and under topical corticosteroids in 97.3% of cases. During follow-up, relapse occurred in 38.9% of cases after a mean time of 2.4±1.2 months.
EPDL appears to be an idiopathic inflammatory dermatosis with a particular topographic expression. The physiopathology could be related to chronic inflammation associated with venous insufficiency and with certain trigger factors. Currently, there are few therapeutic alternatives to topical corticosteroids.
腿部糜烂性脓疱性皮肤病(EPDL)是一种鲜为人知的病症,1987年由拉尼根和科特里尔首次描述。由于其病理生理学尚不清楚,其临床诊断基于排除法。本研究的主要目的是在前瞻性研究中明确其临床特征和结局。次要目的是描述相关疾病、发病情况以及所采用的实验室检查。
这是一项前瞻性研究,纳入了2013年9月1日至2014年10月31日期间法国皮肤病学会血管病 - 皮肤病学组的成员在13个中心挑选的45例患者。有一个为期180天的监测期。分析了36例患者的记录。收集了临床和实验室数据。
患者平均年龄为79.6±9.9岁,男女比例为0.2。患者中,16.7%患有皮肤癌,91.7%患有静脉功能不全。从纳入到第180天,穿着静脉压迫袜的患者比例保持不变。病变为双侧(53%),累及小腿中三分之一,且位于小腿前侧。77.8%的病例实现了完全愈合,愈合时间为2.4±1.2个月,97.3%的病例在局部使用皮质类固醇的情况下实现愈合。在随访期间,38.9%的病例在平均2.4±1.2个月后复发。
EPDL似乎是一种具有特定部位表现的特发性炎症性皮肤病。其病理生理学可能与静脉功能不全相关的慢性炎症以及某些触发因素有关。目前,除了局部皮质类固醇外,治疗选择很少。